ArticleMedical & biological engineering & computing2021
Framework for classification of cancer gene expression data using Bayesian hyper-parameter optimization.
Article in Medical & biological engineering & computing, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Bayesian Optimization-Enhanced Machine Learning for Osteosarcoma Risk Stratification Based on Sphingolipid Metabolism.Human mutation · 2025Article
- Machine learning classification meets migraine: recommendations for study evaluation.The journal of headache and pain · 2024Review
- A platform-independent AI tumor lineage and site (ATLAS) classifier.Communications biology · 2024Article
- An Overview: Genetic Tumor Markers for Early Detection and Current Gene Therapy Strategies.Cancer informatics · 2023Review
- Predicting the Risk of Incident Type 2 Diabetes Mellitus in Chinese Elderly Using Machine Learning Techniques.Journal of personalized medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Computational classification of cancers is an important research problem. Gene expression data has 1000s of features, very few samples, and a class imbalance problem. In this paper, we have proposed a framework for the classification of cancer gene expression profiles. The framework consists of a pipeline of methods for data pre-processing, feature selection, and classification. Data pre-processing is done by standard scaling and normalization of the features. The feature selection is performed in two steps. First, recursive feature elimination (RFE) is used; then, a genetic algorithm is applied only in case RFE results in a feature subset of size more than a specific threshold. Next, is a meta-pool of diverse, individual as well as ensemble classifiers. Hyper-parameters of each member in the meta-pool are optimized using Bayesian Optimization. An algorithm is developed to select the best classifier from the meta-pool based on classification accuracy and computation time taken. We evaluated the framework on 6 publicly available microarray datasets and the PAN-Cancer RNA Sequencing dataset. We found that the classifier selected by the proposed framework produced significant improvement in classification accuracy and computation time required to predict labels for test datasets. A detailed comparison with the state-of-the-art methods shows that the proposed framework outperforms all of them.
Indexed as
Identifiers
34609687What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.